All of that is Phase 2, have to finish Phase 1 first. BTW, they...

First 17 Last

Share
Profile

Follow
SlipSam

361 Posts.

21

16/03/23

15:28

Post #: 66804859
Share

Originally posted by silver46: ↑

the company raised $3.5millions for binding jva with graphenx last year but in quarter report is gone
still havent saw the project execution agreement or install of turbine at bachus
but there is advertising for scholarships so
maybe secret happenings behind scenes

As announced to the market in April 2022, the Company has entered into a binding joint venture agreement (JVA) with GrapheneX. (i)The JVA aims to pursue a net-zero commercial-scale hydrogen refinery and electricity plant in the Latrobe Valley. The focus will be on establishing the demonstration plant at the Company's Bacchus Marsh facility where the Company will commit $3.5m to the JVA to fund a pyrolysis kiln and associated plant to produce char and syngas from COLDry pellets. GrapheneX will supply a 39MW turbine and funding of $3.5m for its installation along with formic acid process equipment which will produce formic acid from the syngas product stream.The formic acid will be used as a favourable hydrogen carrier but can also be used as a livestock feed preservative among other uses. The syngas produced will be used as feedstock to produce low-emission electricity. The JVA will also produce hydrogen derivative products from lignite and waste biomass blends.The JVA is in its early stage formation and is reliant upon key events including regulatory approvals and the installation and completion of the plant by the respective parties as mentioned above. At this point in time, there is therefore a degree of uncertainty associated with the progression of the arrangement to a fully economically viable production facility at both Bacchus Marsh and longer-term, in the Latrobe Valley.Should the facility enter production, the Company has committed to acquire from GrapheneX $8m p.a. of electricity on a 'take or pay' basis. However, GrapheneX must also commit to paying the Company $8m p.a. in license fees associated with using Company facilities. The Company's purchase of electricity may be sold back into the electricity grid with net revenues shared equally between the partners. Offtake and Licence Agreements were not finalised as at the date of this report.The Company will have no claim over any IP generated from the formic acid process or turbine demonstration and GrapheneX will have no claim over any IP generated from the COLDry-pyrolysis kiln demonstration or the char and syngas generation. Each party will continue to have legal ownership over the assets contributed to the JVA.Works are set to commence as soon as the partners complete the project execution plan.The Company has completed a share placement to raise $5m, $3.5m of which was to fund investment into the JVA.

Expand

All of that is Phase 2, have to finish Phase 1 first. BTW, they started Phase 1 commissioning in March last year. Happy Birthday!

They raised $5M last April of which $3.5M was for Phase 2. I wonder how much of that will be left to actually do physical works?
Next quarterly will be interesting.

Last edited by SlipSam: 16/03/23

ECT Price at posting: 0.9¢ Sentiment: Sell Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

LDX

Lumos gains US govt support for study on FebriDx bacterial infection test

SPQ

Superior finds multi-lode shoot system at QLD's Steam Engine gold play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 20 more messages in this thread...

First 17 Last

Add ECT (ASX) to my watchlist

(20min delay)
Last 0.2¢		Change 0.000(0.00%)		Mkt cap ! $6.343M

Open	High	Low	Value	Volume
0.2¢	0.2¢	0.2¢	$10	5.084K

Buyers (Bids)

No.	Vol.	Price($)
64	31058644	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	9813441	31

View Market Depth

No.	Vol.	Price($)
64	31058644	0.002
26	36001532	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	9813441	31
0.004	7713019	12
0.005	3676859	23
0.006	3178567	7
0.007	918333	2

Last trade - 10.02am 03/10/2024 (20 minute delay)

ECT (ASX) Chart

All of that is Phase 2, have to finish Phase 1 first. BTW, they...

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Lumos gains US govt support for study on FebriDx bacterial infection test

Superior finds multi-lode shoot system at QLD's Steam Engine gold play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

All of that is Phase 2, have to finish Phase 1 first. BTW, they...

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Lumos gains US govt support for study on FebriDx bacterial infection test

Superior finds multi-lode shoot system at QLD's Steam Engine gold play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News